Literature DB >> 11971053

Serum leptin level in women with idiopathic intracranial hypertension.

Y Lampl1, Y Eshel, A Kessler, A Fux, R Gilad, M Boaz, Z Matas, M Sadeh.   

Abstract

Leptin is a protein secreted by adipose cells which influences regulation of energy balance and body weight. Idiopathic intracranial hypertension (IIH) is recognised as a neurological disorder mainly affecting obese females. The aim of this study was to evaluate the association between IIH and serum leptin level in 15 obese patients and compare the results with those for 16 obese and 15 non-obese women. A significantly higher serum leptin level was found in patients with IIH than in controls (p<0.0001), and this did not correlate with body mass index (BMI). Serum leptin levels were significantly associated with BMI in both control groups (p<0.0006). Additional factors must therefore be involved in the phenomenon of serum leptin increase beyond weight gain. The cause can only be hypothesised, but it seems that the origin is central, probably hypothalamic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971053      PMCID: PMC1737898          DOI: 10.1136/jnnp.72.5.642

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

Review 1.  Pseudotumor cerebri.

Authors:  Paul W Brazis
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

Review 2.  Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2017-01-31       Impact factor: 4.849

3.  Leptin Elevation as a Risk Factor for Slipped Capital Femoral Epiphysis Independent of Obesity Status.

Authors:  Schuyler J Halverson; Tracy Warhoover; Gregory A Mencio; Steven A Lovejoy; Jeffrey E Martus; Jonathan G Schoenecker
Journal:  J Bone Joint Surg Am       Date:  2017-05-17       Impact factor: 5.284

Review 4.  Pseudotumor cerebri: brief review of clinical syndrome and imaging findings.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-16       Impact factor: 3.825

5.  Transverse Sinus Stenosis Is the Most Sensitive MR Imaging Correlate of Idiopathic Intracranial Hypertension.

Authors:  P P Morris; D F Black; J Port; N Campeau
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-19       Impact factor: 3.825

Review 6.  An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics.

Authors:  Claire A Sheldon; Young Joon Kwon; Grant T Liu; Shana E McCormack
Journal:  Pediatr Res       Date:  2014-11-24       Impact factor: 3.756

7.  Body mass index and the risk of postoperative cerebrospinal fluid leak following transsphenoidal surgery in an Asian population.

Authors:  Ira Sun; Jia Xu Lim; Chun Peng Goh; Shiong Wen Low; Ramez W Kirollos; Chuen Seng Tan; Sein Lwin; Tseng Tsai Yeo
Journal:  Singapore Med J       Date:  2016-09-22       Impact factor: 1.858

Review 8.  Guide to preclinical models used to study the pathophysiology of idiopathic intracranial hypertension.

Authors:  Zerin Alimajstorovic; Connar S J Westgate; Rigmor H Jensen; Sajedeh Eftekhari; James Mitchell; Vivek Vijay; Senali Y Seneviratne; Susan P Mollan; Alexandra J Sinclair
Journal:  Eye (Lond)       Date:  2020-01-02       Impact factor: 3.775

9.  Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension.

Authors:  Connar Sj Westgate; Hannah F Botfield; Zerin Alimajstorovic; Andreas Yiangou; Mark Walsh; Gabrielle Smith; Rishi Singhal; James L Mitchell; Olivia Grech; Keira A Markey; Daniel Hebenstreit; Daniel A Tennant; Jeremy W Tomlinson; Susan P Mollan; Christian Ludwig; Ildem Akerman; Gareth G Lavery; Alexandra J Sinclair
Journal:  JCI Insight       Date:  2021-05-24

10.  A Natural History of Silent Brain Syndrome over 36 Years: A case report.

Authors:  Nathan Pirakitikulr; David T Tse
Journal:  Orbit       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.